Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
167.8 USD
-1.03%
Market Closed
Updated:
Apr 25, 2024
Abbvie Inc
Change in Deffered Taxes
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Change in Deffered Taxes Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Change in Deffered Taxes Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Deffered Taxes | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Deffered Taxes
-$2.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Deffered Taxes
-$962m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Deffered Taxes
-$1.3B
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-21%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Deffered Taxes
-$536.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
-7%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Deffered Taxes
-$837.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Change in Deffered Taxes
$1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Change in Deffered Taxes?
Change in Deffered Taxes
-2.9B
USD
-2.9B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Change in Deffered Taxes amounts to -2.9B USD.
What is Abbvie Inc's Change in Deffered Taxes growth rate?
Change in Deffered Taxes CAGR 3Y
-8%
-8%
Over the last year, the Change in Deffered Taxes growth was -50%. The average annual Change in Deffered Taxes growth rates for Abbvie Inc have been -8% over the past three years .
You don't have any saved screeners yet
